Bioxyne Income Statement

Financials in millions AUD. Fiscal year is July - June.

Millions AUD. Fiscal year is Jul - Jun.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '25 Jun 30, 2025	Jun '24 Jun 30, 2024	Jun '23 Jun 30, 2023	Jun '22 Jun 30, 2022	Jun '21 Jun 30, 2021
Operating Revenue	28.43	9.33	5.15	0.46	2.11
Other Revenue	0.85	0.32	0.14	-	0.09
Revenue	29.28	9.64	5.3	0.46	2.2
Revenue Growth (YoY)	203.66%	81.97%	1042.88%	-78.97%	-5.61%
Cost of Revenue	18.1	5.93	3.73	0.33	1.25
Gross Profit	11.18	3.72	1.57	0.13	0.95
Selling, General & Admin	4.23	3.64	2.69	0.49	1.19
Research & Development	0.17	0.72	-	-	0.09
Operating Expenses	6.08	4.85	3.38	0.59	1.32
Operating Income	5.1	-1.13	-1.82	-0.45	-0.37
Interest Expense	-	-	-	-	-0
Interest & Investment Income	0.02	0.02	0	-	0.02
Currency Exchange Gain (Loss)	-	-	0.04	0	-0.03
Other Non Operating Income (Expenses)	-0.22	-0.21	-0.04	-0	-0.1
EBT Excluding Unusual Items	4.9	-1.32	-1.82	-0.45	-0.5
Impairment of Goodwill	-	-11.57	-	-	-
Gain (Loss) on Sale of Assets	-	-0.08	-	-	-
Asset Writedown	-	-	-0.1	-0.04	-
Pretax Income	4.9	-12.97	-1.92	-0.49	-0.5
Earnings From Continuing Operations	4.9	-12.97	-1.92	-0.49	-0.5
Earnings From Discontinued Operations	-	-0.53	-0.05	-	-
Net Income to Company	4.9	-13.5	-1.96	-0.49	-0.5
Minority Interest in Earnings	-	0.18	0.02	-	-
Net Income	4.9	-13.33	-1.94	-0.49	-0.5
Net Income to Common	4.9	-13.33	-1.94	-0.49	-0.5
Shares Outstanding (Basic)	2,078	1,930	1,344	732	640
Shares Outstanding (Diluted)	2,150	1,930	1,344	732	640
Shares Change (YoY)	11.36%	43.61%	83.52%	14.42%	-
EPS (Basic)	0.00	-0.01	-0.00	-0.00	-0.00
EPS (Diluted)	0.00	-0.01	-0.00	-0.00	-0.00
Free Cash Flow	4.21	-3.74	-1.19	-0.57	0.05
Free Cash Flow Per Share	0.00	-0.00	-0.00	-0.00	-
Gross Margin	38.17%	38.53%	29.55%	29.10%	43.13%
Operating Margin	17.41%	-11.75%	-34.32%	-97.72%	-16.97%
Profit Margin	16.74%	-138.19%	-36.61%	-106.55%	-22.49%
Free Cash Flow Margin	14.37%	-38.77%	-22.45%	-122.27%	2.41%
EBITDA	5.4	-1.08	-1.71	-0.42	-0.36
EBITDA Margin	18.45%	-11.22%	-32.25%	-91.09%	-16.17%
D&A For EBITDA	0.3	0.05	0.11	0.03	0.02
EBIT	5.1	-1.13	-1.82	-0.45	-0.37
EBIT Margin	17.41%	-11.75%	-34.32%	-97.72%	-16.97%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.